Literature DB >> 26780111

Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.

Imran Hasanoglu1, Rahmet Guner2, Ahmet Carhan3, Zeliha Kocak Tufan4, Dilek Yagci-Caglayik5, Tumer Guven6, Gul Ruhsar Yilmaz7, Mehmet A Tasyaran8.   

Abstract

BACKGROUND: Crimean Congo hemorrhagic fever (CCHF) is a fatal disease with a mortality rate of 5-30%. CCHF can be asymptomatic or it may progress with bleeding and cause mortality.
OBJECTIVES: To evaluate relation of viral load with mortality, clinical and laboratory findings in CCHF. STUDY
DESIGN: A total of 126 CCHF patients were included. Serum samples obtained from all patients on admission for measurement of viral load.
RESULTS: In our study, mortality rate was 11.1%. The most important prognostic factor was viral load. Mean viral load was 8.3×10(7)copy/ml and 4.6×10(9)copy/ml in survived and dead patients, respectively (p<0.005). Probability of survival is found to be significantly reduced where AST >1130U/l, ALT >490U/l, CPK >505U/l, LDH >980U/l, platelet count <23×10(3)/l, creatinine >1.4mg/dl, INR >1.3, d-dimer >7100ng/dl, and viral load >1.03×10(8)copy/ml. Patients with 10(8)copy/ml or higher viral load had diarrhea, headache, unconsciousness, bleeding, and seizure significantly more frequently (p<0.05). WBC, hemoglobin, platelet counts were significantly lower whereas AST, ALT, CPK, LDH, creatinine levels, PT and aPTT time, d-dimer levels, and INR were found to be significantly higher in these group.
CONCLUSIONS: There are several severity criteria for prognosis of CCHF. In addition to these parameters, we introduce creatinine as a predictive factor for prognosis. Our study, which has the largest number of patients among studies that evaluate viral load on CCHF shows that viral load is the most effective parameter on mortality.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Creatinine; Crimean Congo hemorrhagic fever; Mortality; Prognosis; Viral load

Mesh:

Substances:

Year:  2016        PMID: 26780111     DOI: 10.1016/j.jcv.2015.12.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

1.  Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin.

Authors:  Katalin Földes; Touraj Aligholipour Farzani; Koray Ergünay; Aykut Ozkul
Journal:  Viruses       Date:  2020-06-25       Impact factor: 5.048

Review 2.  Recent advances in understanding Crimean-Congo hemorrhagic fever virus.

Authors:  David W Hawman; Heinz Feldmann
Journal:  F1000Res       Date:  2018-10-29

Review 3.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks.

Authors:  Barbara Bartolini; Cesare Em Gruber; Marion Koopmans; Tatjana Avšič; Sylvia Bino; Iva Christova; Roland Grunow; Roger Hewson; Gulay Korukluoglu; Cinthia Menel Lemos; Ali Mirazimi; Anna Papa; Maria Paz Sanchez-Seco; Aisha V Sauer; Hervè Zeller; Carla Nisii; Maria Rosaria Capobianchi; Giuseppe Ippolito; Chantal B Reusken; Antonino Di Caro
Journal:  Euro Surveill       Date:  2019-01

4.  A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.

Authors:  Gustaf Ahlén; K Sofia Appelberg; Heinz Feldmann; Matti Sällberg; Ali Mirazimi; David W Hawman; Kimberly Meade-White; Patrick W Hanley; Dana Scott; Vanessa Monteil; Stephanie Devignot; Atsushi Okumura; Friedemann Weber
Journal:  Nat Microbiol       Date:  2020-11-30       Impact factor: 17.745

Review 5.  Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation.

Authors:  Stuart E Lind
Journal:  Heliyon       Date:  2021-01-20

6.  T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.

Authors:  David W Hawman; Kimberly Meade-White; Shanna Leventhal; Aaron Carmody; Elaine Haddock; Kim Hasenkrug; Heinz Feldmann
Journal:  Microorganisms       Date:  2021-01-29

7.  Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.

Authors:  Ronald B Reisler; Chenggang Yu; Michael J Donofrio; Travis K Warren; Jay B Wells; Kelly S Stuthman; Nicole L Garza; Sean A Vantongeren; Ginger C Donnelly; Christopher D Kane; Mark G Kortepeter; Sina Bavari; Anthony P Cardile
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883

8.  Crimean-Congo Hemorrhagic Fever, Kosovo, 2013-2016.

Authors:  Salih Ahmeti; Lindita Berisha; Bahrije Halili; Florim Ahmeti; Ronald von Possel; Corinna Thomé-Bolduan; Anett Michel; Simone Priesnitz; Emil C Reisinger; Stephan Günther; Andreas Krüger; Kurtesh Sherifi; Xhevat Jakupi; Christoph J Hemmer; Petra Emmerich
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

9.  Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015.

Authors:  Dilek Yagci-Caglayik; Bircan Kayaaslan; Derya Yapar; Aysel Kocagul-Celikbas; Aslinur Ozkaya-Parlakay; Mestan Emek; Nurcan Baykam; Hasan Tezer; Gulay Korukluoglu; Aykut Ozkul
Journal:  Euro Surveill       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.